The European pharmacovigilance database, EudraVigilance, contains reports of adverse effects that patients or health professionals suspect to have been caused by the use of one or several drugs, at least within the European Economic Area, encompassing the European Union, Norway, Iceland and Liechtenstein. The reports are collected, analysed, classified using the Medical Dictionary for Regulatory Activities (MedDRA), then recorded in this centralised database by pharmaceutical companies' pharmacovigilance centres (1,2). Since 2012, the public has been able to access certain data from EudraVigilance, through an interface called ADR-reports (www.adrreports.eu).
展开▼
